Quantcast

Navajo neurohepatopathy is caused by a mutation in the MPV17 gene.

Research paper by Charalampos L CL Karadimas, Tuan H TH Vu, Stephen A SA Holve, Penelope P Chronopoulou, Catarina C Quinzii, Stanley D SD Johnsen, Janice J Kurth, Elizabeth E Eggers, Lluis L Palenzuela, Kurenai K Tanji, Eduardo E Bonilla, Darryl C DC De Vivo, Salvatore S DiMauro, Michio M Hirano

Indexed on: 16 Aug '06Published on: 16 Aug '06Published in: The American Journal of Human Genetics



Abstract

Navajo neurohepatopathy (NNH) is an autosomal recessive disease that is prevalent among Navajo children in the southwestern United States. The major clinical features are hepatopathy, peripheral neuropathy, corneal anesthesia and scarring, acral mutilation, cerebral leukoencephalopathy, failure to thrive, and recurrent metabolic acidosis with intercurrent infections. Infantile, childhood, and classic forms of NNH have been described. Mitochondrial DNA (mtDNA) depletion was detected in the livers of two patients, suggesting a primary defect in mtDNA maintenance. Homozygosity mapping of two families with NNH suggested linkage to chromosome 2p24. This locus includes the MPV17 gene, which, when mutated, causes a hepatocerebral form of mtDNA depletion. Sequencing of the MPV17 gene in six patients with NNH from five families revealed the homozygous R50Q mutation described elsewhere. Identification of a single missense mutation in patients with NNH confirms that the disease is probably due to a founder effect and extends the phenotypic spectrum associated with MPV17 mutations.